Instrument Inactif

Communiqués ICON PLC Euronext Dublin

Actions

ICLR

IE0005711209

Recherche biotechnologique et médicale

Temps réel estimé Tradegate 09:18:15 01/10/2026			Varia. 5j.	Varia. 1 janv.
150,92 ^EUR	+652,74%		-8,66%	-

30/09	ICON Public Limited Company : UBS dégrade son opinion à neutre	ZM
18/09	Un dirigeant d'Icon cède des actions pour une valeur de 875 875 dollars, selon un récent document de la SEC	MT

Communiqués

02/09	Medable and ICON Exceed Patient eConsent Adoption Goals for Women's Health Study on Menopause	AQ
20/08	ICON Releases 2025 ICON Cares Report, Highlighting Progress in Patient Impact, Innovation and Sustainability	BU
06/08	ICON Announces Pricing of USD 2.15 Billion Notes	BU
04/08	ICON Announces Private Offering of Notes	BU
31/07	ICON Announces Results of Annual General Meeting	BU
29/07	Icon PLC: Q2 Earnings Snapshot	AQ
29/07	ICON Reports Second Quarter 2026 Results	BU
28/07	ICON announces multi-year collaboration with Anthropic to bring frontier AI to clinical trials	BU
22/07	ICON Schedules Second Quarter 2026 Earnings Conference Call	BU
09/07	INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in ICON plc (ICLR) to Contact Law Firm	AQ
23/06	Icon PLC: Q1 Earnings Snapshot	AQ
23/06	ICON Reports First Quarter 2026 Results	BU
22/06	ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development	BU
17/06	ICON Schedules First Quarter 2026 Earnings Conference Call	BU
27/05	Icon PLC: Q4 Earnings Snapshot	AQ
27/05	ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation	BU
26/05	ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq	BU
13/05	ICON expands US early phase research capabilities with new clinic and outpatient centres	BU
29/04	ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results	BU
24/03	ICON and Advarra Introduce New ‘Research-Ready,’ Connected Site Network Model	BU
16/03	Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm	AQ
18/02	ICON INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating ICON plc on Behalf of ICON Stockholders and Encourages Investors to Contact the Firm	AQ
18/02	ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement	PR
17/02	ICLR ALERT: Securities Fraud Investigation by Block & Leviton Could Allow ICON pcl Investors to Recover Losses	NE
13/02	ICON plc (ICLR) Shares Crater Amid Delayed Financial Report, Investigation Into Revenue Recognition Issues - Hagens Berman	PR